Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMobeus I&g Regulatory News (MIX)

  • There is currently no data for MIX

Interim Management Statement

13 Nov 2014 15:46

RNS Number : 9933W
Mobeus Income & Growth VCT PLC
13 November 2014
 



Mobeus Income & Growth VCT plc

("the Company")

 

INTERIM MANAGEMENT STATEMENT

For the quarter ended 30 September 2014

 

In accordance with Rule 4.3 of the Disclosure and Transparency Rules of the UK Listing Authority, Mobeus Income & Growth VCT plc presents an Interim Management Statement for the quarter ended 30 September 2014. The statement also includes relevant financial information between the end of the period and the date of this statement.

 

NET ASSET VALUE (NAV) AND TOTAL RETURN PER SHARE

At 30 September

2014

At 30 June 2014

Net assets attributable to shareholders

£58,051,319

£67,878,668

Shares in issue

60,850,032

 

60,850,032

 

Net asset value (NAV) per share

95.40 p *

111.55 p

Cumulative dividends paid

64.30 p

47.30 p

Cumulative total return per share (NAV basis) since inception

159.70 p

158.85 p

% return on initial NAV per share of 94.5 pence at inception

69.0 %

68.1 %

 

* The fall in the NAV per share of 16.15 pence is mainly due to the payment of the interim dividend of 17.00 pence per share, detailed below.

 

CUMULATIVE DIVIDENDS

The Company paid an interim dividend of 17.00 pence per share (comprising 15.00 pence from capital and 2.00 pence from income) on 17 September 2014, bringing cumulative dividends paid per share to date to 64.30 pence.

 

NEW INVESTMENT

In July 2014, the Company completed a new investment of £1.46 million to support the MBO of Tharstern Limited, a leading UK supplier of software-based management information systems to the print sector.

 

DIVESTMENTS

The VCT completed the full realisation of its investment in DiGiCo Global Limited in July 2014 through a sale to a new professional audio group backed by Electra Partners, generating net cash proceeds of £3.37 million. The total proceeds of £10.67 million received by the VCT over the life of this investment represent a return on investment of 5.50 times original cost of £1.94 million.

 

Following the period-end, the VCT has realised its investments in Focus Pharma Holdings Limited and Youngman Group Limited for net cash proceeds of £2.48 million and £1.62 million respectively. The Company received total proceeds over the life of its investment in Focus of £4.68 million, representing a return of 3.74 times original cost of £1.25 million. Over the life of the investment in Youngman, total proceeds of £2.42 million were received, representing a return of 2.42 times original cost of £1.00 million.

 

LOAN STOCK REPAYMENTS

A total of £0.22 million has been received in loan stock repayments during the quarter to 30 September 2014, including payments from Tessella Holdings Limited, Westway Services Holdings (2010) Limited and Virgin Wines Holding Company Limited. 

 

A further £0.07 million was received from Fullfield Limited (Motorclean) and Tharstern Limited following the period-end.

 

SHARE BUY-BACKS

The Company did not buy back any of its own shares during the quarter ended 30 September 2014 or following the period-end.

 

MOBEUS VCTS' OFFER FOR SUBSCRIPTION

The Company has announced its intention to launch an offer for subscription later this year to raise up to £15 million.

 

The offer will be promoted by Mobeus Equity Partners LLP, the investment adviser to the Company, and will be made alongside similar offers from Mobeus Income & Growth 2 VCT plc, Mobeus Income & Growth 4 VCT plc and The Income & Growth VCT plc.

 

 

For further information, please contact:

Sarah Penfold, for Mobeus Equity Partners LLP, Company Secretary: 020 7024 7600.

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFFLFIDFLSELF
Date   Source Headline
1st Dec 20237:00 amRNSTotal Voting Rights
27th Nov 20237:00 amRNSTransaction in Own Shares
10th Nov 20231:30 pmRNSInterim Management Statement
1st Nov 20237:00 amRNSTotal Voting Rights
12th Oct 20237:00 amRNSStatement re Change of Registrar
2nd Oct 20237:00 amRNSTotal Voting Rights
27th Sep 20231:00 pmRNSTransaction in Own Shares
21st Sep 202310:15 amRNSDividend Declaration
18th Sep 20231:00 pmRNSHalf-year Report
1st Sep 20237:00 amRNSTotal Voting Rights
1st Aug 20237:00 amRNSTotal Voting Rights
26th Jul 20232:30 pmRNSInvestment Adviser Co-investment Incentive Scheme
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 202312:00 pmRNSTransaction in Own Shares
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 20237:00 amRNSResult of AGM
23rd May 20237:00 amRNSInterim Management Statement
2nd May 202310:00 amRNSTotal Voting Rights
19th Apr 202310:00 amRNSTransaction in Own Shares
13th Apr 20231:00 pmRNSDividend Declaration
4th Apr 20236:07 pmRNSAnnual Financial Report
3rd Apr 20237:00 amRNSTotal Voting Rights
27th Mar 20231:00 pmRNSRealisation of investment: Tharstern Group Limited
1st Mar 20237:00 amRNSTotal Voting Rights
6th Feb 20236:20 pmRNSIssue of Equity and Total Voting Rights
1st Feb 20237:00 amRNSTotal Voting Rights
31st Jan 202311:06 amRNSIssue of Supplementary Prospectus
27th Jan 20232:00 pmRNSNet Asset Value(s)
17th Jan 20235:16 pmRNSDirector Declaration
16th Jan 20237:00 amRNSCHANGE OF ALLOTMENT DATE
22nd Dec 20229:34 amRNSTransaction in Own Shares
5th Dec 20225:49 pmRNSTHE OFFER FOR SUBSCRIPTION IS NOW FULLY SUBSCRIBED
5th Dec 20224:00 pmRNSPartial realisation of investment - EOTH Limited
28th Nov 20228:34 amRNSTransaction in Own Shares and total voting rights
17th Nov 20227:00 amRNSDirector/PDMR Shareholding
16th Nov 20225:41 pmRNSIssue of Equity and Total Voting Rights
9th Nov 20223:40 pmRNSNet Asset Value(s)
9th Nov 20223:00 pmRNSInterim Management Statement
17th Oct 20221:52 pmRNSOffer for Subscription – Update
17th Oct 20229:00 amRNSOffers for Subscription Now Open for Applications
17th Oct 20229:00 amRNSOffers for Subscription Now Open for Applications
12th Oct 20224:05 pmRNSResult of Meeting
10th Oct 202212:00 pmRNSTransaction in Own Shares
5th Oct 20221:50 pmRNSOffers for Subscription and Issue of Prospectus
26th Sep 20227:00 amRNSTransaction in Own Shares
14th Sep 20223:00 pmRNSFundraising Update, Circular and General Meetings
5th Sep 20224:20 pmRNSHalf-year Report
15th Aug 20227:00 amRNSIntention To Launch Joint Offers For Subscription
2nd Aug 20227:00 amRNSNet Asset Value(s)
13th Jun 20222:00 pmRNSRealisation of investment - Media Business Insight

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.